Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideVRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | ABBV | VRTX |
|---|
| Close | 262.51 | 513.26 |
| Market Cap | $464B | $121B |
| 1M | +4.87% | −0.44% |
| P/E (TTM) | 73.7 | 29.7 |
| Forward P/E | 16.8 | 24.0 |
| P/E 5-Yr Percentile | 51 | 52 |
| P/S | 7.2 | 10.4 |
| P/B | — | 6.5 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $3.3B |
| Revenue YoY | +10.2% | +12.5% |
| Gross Margin | 74.7% | 85.3% |
| Latest Quarter EPS | 2.03 | 4.31 |
| Avg Post-Earnings Move | ±1.7% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 1.66% |
| 90-Day Net Insider Buying | −$8.2M | −$2.8M |
ABBV · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
